central to this debate, especially the case of India, which did not recognize product patents in pharmaceuticals before TRIPS … and evolved as a major pharmaceuticals manufacturer and exporter. During the AIDS pandemic when patented products were …-introduction of product patent protection in pharmaceuticals in India in line with the TRIPS agreement, considerable speculation and …